Previous Article | Next Article ![]()
Infection and Immunity, May 2000, p. 3061-3063, Vol. 68, No. 5
Section of Infectious Diseases and Clinical
Immunology, University of Ulm, Ulm,1 and
Clinical Department, Bernhard Nocht Institute for Tropical
Medicine, Hamburg,2 Germany
Received 20 December 1999/Returned for modification 1 February
2000/Accepted 19 February 2000
Levels of soluble Fas ligand (sFasL) in serum were elevated in
patients with Plasmodium falciparum malaria and showed a
significant decline during disease course. sFasL levels that were
elevated before antimalarial treatment began correlated significantly
with depressed total lymphocyte and T-cell counts. These data suggest that Fas-induced apoptosis might play a role in malaria-associated lymphopenia.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Increased Levels of Soluble Fas Ligand in Serum in
Plasmodium falciparum Malaria
*
Corresponding author. Mailing address: Section of
Infectious Diseases and Clinical Immunology, University of Ulm,
Robert-Koch-Str. 8, D-89081 Ulm, Germany. Phone: 49 731 502 4420. Fax:
49 731 502 4422. E-mail:
peter.kern{at}medizin.uni-ulm.de.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»